2024 Accreditation Information

Debates and Didactics in Hematology and Oncology
July 25-28, 2024; Sea Island, Georgia

Jointly provided by Partners for Advancing Clinical Education (PACE) and Bio Ascend LLC.

This activity is supported by independent educational grants from AstraZeneca and Daiichi Sankyo, Inc. 

Target Audience

This activity is intended for oncologists, hematologists, pathologists, clinical scientists, nurse practitioners, physician assistants, nurses, and pharmacists charged with the care of patients with cancer.

Learning Objectives

  • Examine the results and implications of clinical trials that are examining current and emerging therapeutic regimens for patients with solid tumors, including thoracic, breast, head and neck, gynecologic, CNS, gastrointestinal, and genitourinary cancers
  • Assess the safety and efficacy of currently approved and emerging treatments for patients with hematologic malignancies, including patients with lymphoma, leukemia, and multiple myeloma
  • Discuss optimal approaches for integrating novel agents into the treatment armamentarium to maximize the outcomes of patients with hematologic and solid tumor malignancies
  • Evaluate strategies to increase patient and HCP participation in clinical trials in order to address current unmet needs faced by patients with cancer

Disclosure of Conflicts of Interest

PACE requires planners, faculty, and others who are in a position to control the content of this activity to disclose all financial relationships they may have with ineligible companies. All relevant financial relationships are thoroughly vetted and mitigated according to PACE policy. PACE is committed to providing learners with high-quality accredited CE activities and related materials that promote improvements or quality in healthcare and not a specific proprietary business interest of an ineligible company.

Americans with Disabilities Act

Event staff will be glad to assist you with any special needs (i.e., physical, dietary, etc). Please contact ddhoregistration@bioascend.com prior to the live event.

Fee Information

Registration fees are listed on the Register Now page.

Joint Accreditation Statement

Resim1

In support of improving patient care, this activity has been planned and implemented by Partners for Advancing Clinical Education (PACE) and Bio Ascend LLC. PACE is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.

Physician Continuing Education

PACE designates this live activity for a maximum of 23.5 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

ABIM MOC

Successful completion of this CME activity, which includes participation in the evaluation component, enables the participant to earn up to 23.5 MOC points in the American Board of Internal Medicine’s (ABIM) Maintenance of Certification (MOC) program. It is the CME activity provider’s responsibility to submit participant completion information to ACCME for the purpose of granting ABIM MOC credit.

Upon successfully completing the post-test with a passing score of 75% or better and activity evaluation, your certificate will be made available immediately. By selecting ABIM MOC credit, you are giving the providers permission to collect and submit the required individual learner completion data for the selected certifying boards via PARS.

Disclosure of Unlabeled Use

This educational activity may contain discussion of published and/or investigational uses of agents that are not indicated by the FDA. The planners of this activity do not recommend the use of any agent outside of the labeled indications.

The opinions expressed in the educational activity are those of the faculty and do not necessarily represent the views of the planners. Please refer to the official prescribing information for each product for discussion of approved indications, contraindications, and warnings.

Disclaimer

Participants have an implied responsibility to use the newly acquired information to enhance patient outcomes and their own professional development. The information presented in this activity is not meant to serve as a guideline for patient management. Any procedures, medications, or other courses of diagnosis or treatment discussed or suggested in this activity should not be used by clinicians without evaluation of their patient’s conditions and possible contraindications and/or dangers in use, review of any applicable manufacturer’s product information, and comparison with recommendations of other authorities.

How To Claim Credit

To receive CE credit, learners must follow these steps:

  1. Visit https://paceducation.com/DDHO2024
  2. Complete the activity evaluation
  3. Upon completion of all evaluation questions, your credit will be made available for download immediately